Alpha Tau Medical Reports Mid-Year Financials
Company Announcements

Alpha Tau Medical Reports Mid-Year Financials

Alpha Tau Medical Ltd (DRTS) has released an update.

Alpha Tau Medical Ltd., a medical technology company, has released its unaudited interim consolidated financial statements for the period ending June 30, 2024. The report reveals a decrease in total assets from $107,388 thousand to $96,048 thousand over six months. Additionally, the statement shows an increase in the company’s accumulated deficit, underscoring the ongoing expenses in research, development, and marketing.

For further insights into DRTS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAlpha Tau’s Alpha DaRT Gains FDA Study Approval
GlobeNewswireAlpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
TheFlyAlpha Tau announces FDA approval of IDE to initiate study of Alpha DaRT
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App